BRAF and melanoma: Oncogenic mutations in the oncoprotein BRAF, which encodes the growth signal transduction serine/threonine protein kinase B-Raf, are found in approximately 50% of melanomas and result in constitutive activation of the RAS/mitogen-activated protein kinase (MAPK) pathway.